drugset / Trial / NCT00211653

Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery

NCT00211653 ↗

Phase 1/2 Completed 102 enrolled Minneapolis Veterans Affairs Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if Acetylcysteine is effective in preventing renal failure associated with cardiac surgery

Timeline

Start
2003-04
Primary completion
—
Completion
2006-11

Outcome

Missed primary endpoint

paper CONCLUSION: Prophylactic perioperative NAC administration does not prevent AKI after cardiac surgery. PMID 18513531 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 600 mg Oral

Indications